These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37446377)

  • 1. Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases.
    Jian JY; Osheroff N
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basis for the discrimination of supercoil handedness during DNA cleavage by human and bacterial type II topoisomerases.
    Jian JY; McCarty KD; Byl JAW; Guengerich FP; Neuman KC; Osheroff N
    Nucleic Acids Res; 2023 May; 51(8):3888-3902. PubMed ID: 36999602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of DNA Supercoil Handedness during Catenation Catalyzed by Type II Topoisomerases.
    Dalvie ED; Stacy JC; Neuman KC; Osheroff N
    Biochemistry; 2022 Oct; 61(19):2148-2158. PubMed ID: 36122251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases.
    Vidmar V; Vayssières M; Lamour V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of viral topoisomerase II to discern the handedness of supercoiled DNA: bimodal recognition of DNA geometry by type II enzymes.
    McClendon AK; Dickey JS; Osheroff N
    Biochemistry; 2006 Sep; 45(38):11674-80. PubMed ID: 16981727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin Architectural Factors as Safeguards against Excessive Supercoiling during DNA Replication.
    Ahmed SM; Dröge P
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical basis for the interactions of type I and type II topoisomerases with DNA.
    Osheroff N
    Pharmacol Ther; 1989; 41(1-2):223-41. PubMed ID: 2540496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I.
    Gentry AC; Juul S; Veigaard C; Knudsen BR; Osheroff N
    Nucleic Acids Res; 2011 Feb; 39(3):1014-22. PubMed ID: 20855291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers.
    Zechiedrich EL; Osheroff N
    EMBO J; 1990 Dec; 9(13):4555-62. PubMed ID: 2176156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
    Tse-Dinh YC
    Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase II Poisons: Converting Essential Enzymes into Molecular Scissors.
    Vann KR; Oviatt AA; Osheroff N
    Biochemistry; 2021 Jun; 60(21):1630-1641. PubMed ID: 34008964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G; Tolstonog GV; Sabasch M; Traub P
    DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?
    Bax BD; Sutormin D; McDonald NQ; Burley GA; Shelkovnikova T
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase Assays.
    Nitiss JL; Kiianitsa K; Sun Y; Nitiss KC; Maizels N
    Curr Protoc; 2021 Oct; 1(10):e250. PubMed ID: 34606690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanistic and functional insights into DNA topoisomerases.
    Chen SH; Chan NL; Hsieh TS
    Annu Rev Biochem; 2013; 82():139-70. PubMed ID: 23495937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.
    McClendon AK; Osheroff N
    Biochemistry; 2006 Mar; 45(9):3040-50. PubMed ID: 16503659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML; Hsu MT
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break.
    Liu LF; Liu CC; Alberts BM
    Cell; 1980 Mar; 19(3):697-707. PubMed ID: 6244895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia DNA topoisomerase I: evidence supporting a free rotation mechanism for DNA supercoil relaxation.
    Stivers JT; Harris TK; Mildvan AS
    Biochemistry; 1997 Apr; 36(17):5212-22. PubMed ID: 9136883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.